Resmed (RSMDF) Other Non-Current Assets (2010 - 2026)
Resmed's (RSMDF) quarterly Other Non-Current Assets came in at $457.4 million in Q2 2026, up 146.12% on a YoY basis from $185.8 million in Q2 2025, and up 117.04% quarter-over-quarter from $210.7 million in Q1 2026.
Analysis
Resmed (RSMDF) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Other Non-Current Assets for 17 consecutive years, with $457.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 146.12% year-over-year to $457.4 million; the trailing twelve-month figure through Jun 2026 stood at $457.4 million (up 146.12% YoY), and the FY2026 full-year result was $457.4 million, up 146.12% from the prior year.
- Other Non-Current Assets rose to $457.4 million in Q2 2026 per RSMDF's latest filing, from $210.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $457.4 million in Q2 2026 and bottomed at $169.4 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $237.9 million across 5 years, with a median of $235.4 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets plunged 37.03% in 2025, then jumped 146.12% in 2026.
- Over 5 years, Other Non-Current Assets stood at $260.2 million in 2022, then advanced by 6.02% to $275.8 million in 2023, then sank by 34.31% to $181.2 million in 2024, then rose by 7.01% to $193.9 million in 2025, then jumped by 135.91% to $457.4 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $457.4 million, $210.7 million, and $193.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 457.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 457.39 Mn |
| Mar 31, 2026 | 210.73 Mn |
| Dec 31, 2025 | 193.88 Mn |
| Sep 30, 2025 | 189.84 Mn |
| Jun 30, 2025 | 185.84 Mn |
| Mar 31, 2025 | 174.63 Mn |
| Dec 31, 2024 | 181.18 Mn |
| Sep 30, 2024 | 278.85 Mn |
| Jun 30, 2024 | 284.00 Mn |
| Mar 31, 2024 | 277.33 Mn |
| Dec 31, 2023 | 275.82 Mn |
| Sep 30, 2023 | 265.11 Mn |
| Jun 30, 2023 | 262.45 Mn |
| Mar 31, 2023 | 270.87 Mn |
| Dec 31, 2022 | 260.16 Mn |
| Sep 30, 2022 | 173.43 Mn |
| Jun 30, 2022 | 171.75 Mn |
| Mar 31, 2022 | 169.40 Mn |
| Dec 31, 2021 | 165.54 Mn |
| Sep 30, 2021 | 162.99 Mn |